Understanding AL amyloidosis: Treatment and diagnosis
The pharmacovigilance system (PV) in Uganda is overseen by the National Drug Authority, established in 1993 to ensure medicine safety.
The NDA provides guidelines for healthcare stakeholders and hosts the National Pharmacovigilance Centre for product safety. Uganda works with the WHO for drug monitoring, evaluating safety before market entry and responding to adverse reactions.
Healthcare professionals report issues using forms and digital tools, with evolving standards towards electronic reporting.
Understanding AL amyloidosis: Treatment and diagnosis
Understanding multiple myeloma: Challenges and solutions
Enhancing medicine safety monitoring in Zambia
The evolution of pharmacovigilance: Lessons from thalidomide
Understanding pharmacovigilance challenges in Lesotho & Swaziland
Understanding pharmacovigilance in Kenya
Understanding pharmacovigilance in Namibia
Management of surgical complications in thyroid surgery
Improving results of FNAC in thyroid nodules